AR - EGLN2

H. sapiens

SDL interaction

Identifiers

Gene Name Gene ID Diseases Drugs GO terms Orthologs
AR ENSG00000169083 prostate
BICALUTAMIDE
DANAZOL
DROMOSTANOLONE PROPIONATE
ENZALUTAMIDE
ETHYLESTRENOL
FLUOXYMESTERONE
FLUTAMIDE
METHYLTESTOSTERONE
NANDROLONE DECANOATE
NANDROLONE PHENPROPIONATE
NILUTAMIDE
OXANDROLONE
OXYMETHOLONE
STANOZOLOL
TESTOSTERONE
TESTOSTERONE CYPIONATE
TESTOSTERONE ENANTHATE
TESTOSTERONE PROPIONATE
TESTOSTERONE UNDECANOATE
RNA polymerase II core promoter proximal region sequence-specific DNA binding
transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding
RNA polymerase II transcription factor binding
DNA binding
chromatin binding
transcription factor activity, sequence-specific DNA binding
RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding
androgen receptor activity
receptor binding
steroid binding
androgen binding
protein binding
beta-catenin binding
transcription factor binding
zinc ion binding
enzyme binding
transcription regulatory region DNA binding
protein dimerization activity
ATPase binding
POU domain binding

No GO terms in record

EGLN2 ENSG00000269858

No diseases in record

No drugs in record

protein binding
ferrous iron binding
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors
oxygen sensor activity
L-ascorbic acid binding
peptidyl-proline 4-dioxygenase activity
egl-9 (C. elegans)